CVS, Optum Exclude Inhalers, Switch Diabetes Supplies for ’21 With Chart: Major PBMs Release 2021 Formulary Exclusions
October
8
Editor’s Note: A previous version of this article misstated how OptumRx is covering Tecfidera, Ruxience, Rituxan and Truxima. This version has been corrected.
CVS Health Corp.’s Caremark will exclude 57 medications from its 2021 formulary and add six back. Meanwhile, UnitedHealth Group’s OptumRx subsidiary will exclude 19 medications and products while adding back five and implementing restrictions on others.
© 2025 MMIT
